What's new

Human medicines European public assessment report (EPAR): Penbraya, Meningococcal groups A, C, W, Y conjugate and group B vaccine (recombinant, adsorbed), Date of authorisation: 14/11/2024, Status: Withdrawn

Human medicines European public assessment report (EPAR): Penbraya, Meningococcal groups A, C, W, Y conjugate and group B vaccine (recombinant, adsorbed), Date of authorisation: 14/11/2024, Status: Withdrawn

Feb 9, 2025 - 21:46
 0
Human medicines European public assessment report (EPAR): Penbraya, Meningococcal groups A, C, W, Y conjugate and group B vaccine (recombinant, adsorbed), Date of authorisation: 14/11/2024, Status: Withdrawn
Human medicines European public assessment report (EPAR): Penbraya, Meningococcal groups A, C, W, Y conjugate and group B vaccine (recombinant, adsorbed), Date of authorisation: 14/11/2024, Status: Withdrawn
Read More

Tags:

Previous Article

Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) me...

Next Article

Meeting of the Executive Steering Group on Shortages and Safety of Medicinal Pro...

Related Posts

Human medicines European public assessment report (EPAR): Breyanzi, lisocabtagene maraleucel, Date of authorisation: 04/04/2022, Revision: 8, Status: Authorised

Human medicines European public assessment report (EPAR...

Apr 11, 2025  0

Management Board meeting: 13 March 2025, European Medicines Agency, Amsterdam, the Netherlands, 13 March 2025

Management Board meeting: 13 March 2025, European Medic...

Mar 12, 2025  0

RoActemra

RoActemra

Apr 1, 2025  0